Kiniksa Pharmaceuticals International, plc: directors' dealings · United States · SEC (Form 4) Explore the full directors' dealings record of Kiniksa Pharmaceuticals International, plc, a publicly traded company based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Market capitalisation: €8.6m. The latest transaction was filed on 2 June 2026 (Attribution). Among the most active insiders: Tessari Eben. All data is free.
€321,795
1 ops.
Sell Volume
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 2 June 2026
All Executives61 Thresholds0 Prospectus0 Other0
Declarations 61 total
◆ Director · Executives · 29 May 2026
6,078 shares 0Class A Ordinary Shares SEC:0001193125-26-253615:0
◆ Director · Executives · 29 May 2026
6,078 shares 0Class A Ordinary Shares SEC:0001193125-26-253615:1
◇ Director · Executives · 29 May 2026
2,799 shares Class A Ordinary Share SEC:0001337798-26-000002:0
◇ CHAIRMAN & CEO · Executives · 20 May 2025
2,349 shares @ US$1.59 1.0% of flow Class A Ordinary Share SEC:0001415889-25-014167:0
◇ CHIEF OPERATING OFFICER · Executives · 19 May 2025
7,000 shares @ US$3.80 11.5% of flow Class A Ordinary Share SEC:0001415889-25-013944:0
◇ CHAIRMAN & CEO · Executives · 13 May 2025
2,872 shares @ US$1.59 1.2% of flow Class A Ordinary Share SEC:0001415889-25-013170:0
◇ CHIEF MEDICAL OFFICER · Executives · 7 May 2025
200 shares @ US$3.80 1.8% of flow Class A Ordinary Share SEC:0001415889-25-012541:0
◇ CHIEF ACCOUNTING OFFICER · Executives · 7 May 2025
229 shares @ US$8.83 0.9% of flow Class A Ordinary Share SEC:0001415889-25-012532:0
◇ CHAIRMAN & CEO · Executives · 7 May 2025
1,965 shares @ US$1.59 0.8% of flow Class A Ordinary Share SEC:0001415889-25-012571:0
◇ CHIEF COMMERCIAL OFFICER · Executives · 2 May 2025
3,850 shares @ US$17.76 10.0% of flow Class A Ordinary Share SEC:0001415889-25-011992:0
◇ CHIEF FINANCIAL OFFICER · Executives · 29 Apr 2025
20,000 shares @ US$15.52 22.2% of flow Class A Ordinary Share SEC:0001415889-25-011690:0
◇ CHIEF COMMERCIAL OFFICER · Executives · 29 Apr 2025
15,000 shares @ US$15.52 33.7% of flow Class A Ordinary Share SEC:0001415889-25-011692:0
◇ CHIEF FINANCIAL OFFICER · Executives · 26 Apr 2025
990 shares Class A Ordinary Share SEC:0001415889-25-011502:0
▼ CHIEF COMMERCIAL OFFICER · Executives · 21 Apr 2025
18,259 shares @ US$20.29 53.0% of flow Class A Ordinary Share SEC:0001415889-25-011209:0
◇ CHIEF OPERATING OFFICER · Executives · 14 Apr 2025
7,000 shares @ US$3.80 11.4% of flow Class A Ordinary Share SEC:0001415889-25-010808:0
◇ CHIEF COMMERCIAL OFFICER · Executives · 7 Apr 2025
2,477 shares Class A Ordinary Share SEC:0001415889-25-010478:0
◇ CHIEF FINANCIAL OFFICER · Executives · 7 Apr 2025
2,694 shares Class A Ordinary Share SEC:0001415889-25-010485:0
◇ CHIEF MEDICAL OFFICER · Executives · 7 Apr 2025
2,498 shares Class A Ordinary Share SEC:0001415889-25-010480:0
◇ CHIEF ACCOUNTING OFFICER · Executives · 7 Apr 2025
3,933 shares Class A Ordinary Share SEC:0001415889-25-010476:0
◇ CHAIRMAN & CEO · Executives · 7 Apr 2025
9,992 shares Class A Ordinary Share SEC:0001415889-25-010482:0
◇ CHIEF OPERATING OFFICER · Executives · 7 Apr 2025
2,726 shares Class A Ordinary Share SEC:0001415889-25-010487:0
◇ CHIEF MEDICAL OFFICER · Executives · 1 Apr 2025
1,624 shares Class A Ordinary Share SEC:0001415889-25-010007:0
◇ CHIEF COMMERCIAL OFFICER · Executives · 1 Apr 2025
1,611 shares Class A Ordinary Share SEC:0001415889-25-010012:0
◇ CHAIRMAN & CEO · Executives · 1 Apr 2025
6,481 shares Class A Ordinary Share SEC:0001415889-25-009993:0
◇ CHIEF ACCOUNTING OFFICER · Executives · 1 Apr 2025
2,557 shares Class A Ordinary Share SEC:0001415889-25-009991:0
25 of 61 declarations
Load more (36 remaining)